Global Therapeutic Protein Market Growth 2022-2028

Global Therapeutic Protein Market Growth 2022-2028

Product Code:208379

Published Date: Jan 05,2022

Pages: 102

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

As the global economy mends, the 2021 growth of Therapeutic Protein will have significant change from previous year. According to our (LP Information) latest study, the global Therapeutic Protein market size is USD  million in 2022 from USD  million in 2021, with a change of % between 2021 and 2022. The global Therapeutic Protein market size will reach USD  million in 2028, growing at a CAGR of  % over the analysis period.

The United States Therapeutic Protein market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Therapeutic Protein market, reaching US$  million by the year 2028. As for the Europe Therapeutic Protein landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Therapeutic Protein players cover Amgen, Abbott Laboratories, AstraZeneca, and Baxter International, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Protein market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
    Monoclonal Antibodies
    Erythropoietin
    Insulin
    Interferon
    Human Growth Hormone
    Follicle Stimulating Hormone
    Blood Clotting Factors

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
    Pharmaceutical Companies
    Healthcare Service Providers
    Research Organizations
    Academic Research Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
    Amgen
    Abbott Laboratories
    AstraZeneca
    Baxter International
    Boehringer Ingelheim
    Chugai Pharmaceutical
    Diasome Pharmaceuticals
    Eli Lilly
    GeneScience Pharmaceuticals
    Generex Biotechnology
    Genentech